This is a synthetic peptide designed for use in combination with anti-DYNLL1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
DYNLL1
(Dynein, Light Chain, LC8-Type 1 (DYNLL1))
Hintergrund
Cytoplasmic dyneins are large enzyme complexes with a molecular mass of about 1,200 kD. They contain two force-producing heads formed primarily from dynein heavy chains, and stalks linking the heads to a basal domain, which contains a varying number of accessory intermediate chains. The complex is involved in intracellular transport and motility. DYNLL1 is a light chain and exists as part of this complex but also physically interacts with and inhibits the activity of neuronal nitric oxide synthase. Binding of this protein destabilizes the neuronal nitric oxide synthase dimer, a conformation necessary for activity, and it may regulate numerous biologic processes through its effects on nitric oxide synthase activity.
Protein Interaction Partner: BCAS1,DLGAP1,DLGAP1,DYNLL1,MYO5A,NFKBIA,PAN2,PKIA,PKIB,PKIG,SLC25A10,ACTB,ACTC1,ACTG1,ALDOA,BCAS1,BCL2L11,C14orf1,CA2,CACNB1,CLIP2,CS,DAZ1,DLG4,DLGAP1,DNAJB9,DNM2,DNM3,DNMT1,DYNC1H1,DYNC1I1,DYNLL1,EEF1A1,GAPDH,GLUD1,GLUL,GPHN,GRIN3A,HIP1R,HSPA8,LDHA,MAP1B